Pfizer Hopes To Keep Sutent Successes Coming – Forbes
Pfizer Hopes To Keep Sutent Successes Coming – Forbes
 Reuters |
Pfizer Hopes To Keep Sutent Successes Coming
Forbes Results from a late-stage Pfizer trial studying the effectiveness of Sutent in stemming the advancement of a rare pancreatic cancer were so encouraging that the company called it quits and extended the treatment to placebo-popping patients. Pancreatic Drug Trial Halted on Promising Results Pfizer drug has good news for patients with rare cancer form |
Popularity: 1% [?]
Tags: cnn, Health, money, news, online, reutersRelated News
